The gift will support the development of a $1 billion, 190,000-square-foot comprehensive cancer campus in Irvine, California. Scheduled to open in 2022, the Lennar Foundation Cancer Center at City of Hope Orange County will bring together more than a thousand physicians and researchers working to develop targeted treatments for different kinds of cancer; a range of treatment options — from chemotherapy to immunotherapy — for combatting even the most aggressive cancers; new ways to prevent and treat cancer in its early stages, including highly targeted genomics and precision medicine innovations; and supportive care programs. The gift also will help establish a network of advanced cancer care and research facilities to help accelerate the availability of groundbreaking treatments.
"City of Hope is a leader in the treatment of and race to find a cure for cancer, and it's gratifying to know that, with this gift, we will make a positive impact by expanding access to care and advancing the research that will treat, prevent, and ultimately eliminate cancer," said Lennar Corporation co-CEO and co-president Jon Jaffe, who serves on City of Hope's Construction Industries Alliance Leadership Advisory Council. "We hope this contribution will encourage other philanthropic leaders to support City of Hope in the fight against cancer."
"With this gift, we will achieve the nexus of unsurpassed medical expertise, future-focused communities, groundbreaking technology, and innovation, all for the single purpose of saving lives," said Robert W. Stone, City of Hope's president, CEO, and Helen and Morgan Chu Chief Executive Officer Distinguished Chair. "This partnership supports a system of care delivery that provides state-of-the-art treatments, the latest scientific and medical discoveries, and unprecedented access that will serve as a model across the country."